BiotechTube
Home/SRTD biotech/Dr. Bernd Hoffmann
DB

Dr. Bernd Hoffmann

CEO, CSO & Co-Founder

SRTD biotech

Therapeutic Areas

OncologyAutoimmune DiseasesViral Diseases

SRTD biotech Pipeline

DrugIndicationPhase
seRNA 001Hepatocellular Carcinoma (HCC)Preclinical
seRNA 002Lung CancerPreclinical
seRNA 003GlioblastomaPreclinical
seRNA 004Viral DiseasesResearch
seRNA 005Autoimmune DiseasesResearch

Leadership Team at SRTD biotech

DG
Dr. Georg Lautscham
Consultant, CCO, CBO
View full SRTD biotech profile